Cargando…

Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders

BACKGROUND: Over the last decade, the transgenic N-methyl-D-aspartate receptor (NMDAR) NR1-knockdown mouse (NR1(neo−/−)) has been investigated as a glutamate hypofunction model for schizophrenia. Recent research has now revealed that the model also recapitulates cognitive and negative symptoms in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wesseling, Hendrik, Guest, Paul C, Lee, Chi-Ming, Wong, Erik HF, Rahmoune, Hassan, Bahn, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109791/ https://www.ncbi.nlm.nih.gov/pubmed/25061506 http://dx.doi.org/10.1186/2040-2392-5-38

Ejemplares similares

Proteomic analysis of post mortem brain tissue from autism patients: evidence for opposite changes in prefrontal cortex and cerebellum in synaptic connectivity-related proteins
por: Broek, Jantine AC, et al.
Publicado: (2014)

Proteomic profiling in schizophrenia: enabling stratification for more effective treatment
por: Guest, Paul C, et al.
Publicado: (2013)

Identification of an age-dependent biomarker signature in children and adolescents with autism spectrum disorders
por: Ramsey, Jordan M, et al.
Publicado: (2013)

Proteomic Enrichment Analysis of Psychotic and Affective Disorders Reveals Common Signatures in Presynaptic Glutamatergic Signaling and Energy Metabolism
por: Gottschalk, Michael G., et al.
Publicado: (2015)

A brain proteomic investigation of rapamycin effects in the Tsc1(+/−) mouse model
por: Wesseling, Hendrik, et al.
Publicado: (2017)

Comparison of Peripheral and Central Schizophrenia Biomarker Profiles
por: Harris, Laura W., et al.
Publicado: (2012)

The Role of Zinc and NMDA Receptors in Autism Spectrum Disorders
por: Lee, Kevin, et al.
Publicado: (2022)

Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function
por: Martins-de-Souza, Daniel, et al.
Publicado: (2012)

Diabetic db/db mice exhibit central nervous system and peripheral molecular alterations as seen in neurological disorders
por: Ernst, A, et al.
Publicado: (2013)

The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia
por: Martins-de-Souza, Daniel, et al.
Publicado: (2012)

Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome
por: Steeb, Hannah, et al.
Publicado: (2014)

Antidepressant Interactions with the NMDA NR1-1b Subunit
por: Raabe, Richard, et al.
Publicado: (2008)

Cloning and Phylogenetic Analysis of NMDA Receptor Subunits NR1, NR2A and NR2B in Xenopus laevis Tadpoles
por: Ewald, Rebecca C., et al.
Publicado: (2009)

Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients
por: Martins-de-Souza, D, et al.
Publicado: (2012)

Expression of NR1 subunit of NMDA receptor and PSD-93/95 in rat hippocampus affected by NR1/NR2 antisense oligodeoxynucleotide
por: Vrajová, Monika, et al.
Publicado: (2010)

Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia
por: Catts, Vibeke Sørensen, et al.
Publicado: (2015)

Proteomics: improving biomarker translation to modern medicine?
por: Guest, Paul C, et al.
Publicado: (2013)

Mechanism of differential control of NMDA receptor activity by NR2 subunits
por: Gielen, Marc, et al.
Publicado: (2009)

Targeted Multiplexed Selected Reaction Monitoring Analysis Evaluates Protein Expression Changes of Molecular Risk Factors for Major Psychiatric Disorders
por: Wesseling, Hendrik, et al.
Publicado: (2014)

Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients
por: Jiang, Xin-Yue, et al.
Publicado: (2020)

Synaptic NR2A- but not NR2B-Containing NMDA Receptors Increase with Blockade of Ionotropic Glutamate Receptors
por: von Engelhardt, Jakob, et al.
Publicado: (2009)

A Naturally Occurring Null Variant of the NMDA Type Glutamate Receptor NR3B Subunit Is a Risk Factor of Schizophrenia
por: Matsuno, Hitomi, et al.
Publicado: (2015)

Plasticity of NMDA receptor NR2B subunit in memory and chronic pain
por: Zhuo, Min
Publicado: (2009)

Potentiation of Glycine-Gated NR1/NR3A NMDA Receptors Relieves Ca(2+)-Dependent Outward Rectification
por: Madry, Christian, et al.
Publicado: (2010)

NR4A1 Knockdown Suppresses Seizure Activity by Regulating Surface Expression of NR2B
por: Zhang, Yanke, et al.
Publicado: (2016)

Autism & Gluten: The Proof By Regression!
por: Rahmoune, Hakim, et al.
Publicado: (2018)

Molecular Abnormalities in BTBR Mice and Their Relevance to Schizophrenia and Autism Spectrum Disorders: An Overview of Transcriptomic and Proteomic Studies
por: Kisaretova, Polina, et al.
Publicado: (2023)

EHMTI-0308. Cortical spreading depression increases NR2A/NR2B ratio by altering numbers of nr2a and nr2b subunit-containing nmda receptors in the hippocampus
por: Hansrivijit, P, et al.
Publicado: (2014)

Pharmacological isolation of postsynaptic currents mediated by NR2A- and NR2B-containing NMDA receptors in the anterior cingulate cortex
por: Wu, Long-Jun, et al.
Publicado: (2007)

Corrigendum: NR4A1 Knockdown Suppresses Seizure Activity by Regulating Surface Expression of NR2B
por: Zhang, Yanke, et al.
Publicado: (2017)

Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia
por: Kannan, G, et al.
Publicado: (2017)

Cingulate NMDA NR2B receptors contribute to morphine-induced analgesic tolerance
por: Ko, Shanelle W, et al.
Publicado: (2008)

Biomarker discovery in human cerebrospinal fluid: the need for integrative metabolome and proteome databases
por: Schwarz, Emanuel, et al.
Publicado: (2012)

Brain NMDA Receptors in Schizophrenia and Depression
por: Adell, Albert
Publicado: (2020)

An investigation of reasoning by analogy in schizophrenia and autism spectrum disorder
por: Krawczyk, Daniel C., et al.
Publicado: (2014)

Comparison of eye movements in schizophrenia and autism spectrum disorder
por: Shiino, Tomoko, et al.
Publicado: (2019)

The role of proteomics in depression research
por: Martins-de-Souza, Daniel, et al.
Publicado: (2009)

Clinical and autoimmune features of a patient with autism spectrum disorder seropositive for anti—NMDA-receptor autoantibody
por: Gréa, Hélène, et al.
Publicado: (2017)

The A-Current Modulates Learning via NMDA Receptors Containing the NR2B Subunit
por: Fontán-Lozano, Ángela, et al.
Publicado: (2011)

Selective Regulation of NR2B by Protein Phosphatase-1 for the Control of the NMDA Receptor in Neuroprotection
por: Farinelli, Mélissa, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l82ecplghn0nv1jhq9i9tr5oc7